NL8902361A - Peptidesynthese in vaste fase. - Google Patents

Peptidesynthese in vaste fase. Download PDF

Info

Publication number: NL8902361A
Authority: NL; Netherlands
Prior art keywords: meth; acryloyl; dmf; wash; distilled water
Prior art date: 1988-09-24

Application number

NL8902361A

Other languages

English (en)

Dutch (nl)

Original Assignee

Expansia Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-09-24

Filing date

1989-09-21

Publication date

1990-04-17

1989-09-21 Application filed by Expansia Sa filed Critical Expansia Sa

1990-04-17 Publication of NL8902361A publication Critical patent/NL8902361A/nl

Links

238000010647 peptide synthesis reaction Methods 0.000 title claims description 8
239000011347 resin Substances 0.000 claims description 35
229920005989 resin Polymers 0.000 claims description 35
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
108090000765 processed proteins & peptides Proteins 0.000 claims description 25
238000005859 coupling reaction Methods 0.000 claims description 14
239000012153 distilled water Substances 0.000 claims description 14
229940024606 amino acid Drugs 0.000 claims description 13
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
150000001413 amino acids Chemical class 0.000 claims description 12
230000008878 coupling Effects 0.000 claims description 12
238000010168 coupling process Methods 0.000 claims description 12
238000000034 method Methods 0.000 claims description 12
238000005406 washing Methods 0.000 claims description 12
150000008064 anhydrides Chemical class 0.000 claims description 11
229920001577 copolymer Polymers 0.000 claims description 10
125000006239 protecting group Chemical group 0.000 claims description 10
239000000178 monomer Substances 0.000 claims description 9
239000007790 solid phase Substances 0.000 claims description 7
239000004925 Acrylic resin Substances 0.000 claims description 6
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 6
238000006386 neutralization reaction Methods 0.000 claims description 6
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 4
239000002253 acid Substances 0.000 claims description 4
150000007513 acids Chemical class 0.000 claims description 4
125000000539 amino acid group Chemical group 0.000 claims description 4
239000011159 matrix material Substances 0.000 claims description 4
229960004441 tyrosine Drugs 0.000 claims description 4
125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 claims description 3
WLPAQAXAZQUXBG-UHFFFAOYSA-N 1-pyrrolidin-1-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCCC1 WLPAQAXAZQUXBG-UHFFFAOYSA-N 0.000 claims description 3
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 3
HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 3
UTDSSTFBUGDVAI-LURJTMIESA-N (2s)-1-prop-2-enoylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)C=C UTDSSTFBUGDVAI-LURJTMIESA-N 0.000 claims description 2
PPRBGMXQDAMDAB-BYPYZUCNSA-N (2s)-2-(prop-2-enoylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)C=C PPRBGMXQDAMDAB-BYPYZUCNSA-N 0.000 claims description 2
UHWCAAMSQLMQKV-ZETCQYMHSA-N (2s)-3-methyl-2-(prop-2-enoylamino)butanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)C=C UHWCAAMSQLMQKV-ZETCQYMHSA-N 0.000 claims description 2
ZCGAXQUVEXKCCZ-UHFFFAOYSA-N 1,1-diaminobut-3-en-2-one Chemical compound C(C=C)(=O)C(N)N ZCGAXQUVEXKCCZ-UHFFFAOYSA-N 0.000 claims description 2
YVNNRQCAABDUMX-UHFFFAOYSA-N 1-(4-methylpiperazin-1-yl)prop-2-en-1-one Chemical compound CN1CCN(C(=O)C=C)CC1 YVNNRQCAABDUMX-UHFFFAOYSA-N 0.000 claims description 2
HNKNCTHACSPOPO-UHFFFAOYSA-N 1-(azepan-1-yl)prop-2-en-1-one Chemical compound C=CC(=O)N1CCCCCC1 HNKNCTHACSPOPO-UHFFFAOYSA-N 0.000 claims description 2
XLPJNCYCZORXHG-UHFFFAOYSA-N 1-morpholin-4-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCOCC1 XLPJNCYCZORXHG-UHFFFAOYSA-N 0.000 claims description 2
RESPXSHDJQUNTN-UHFFFAOYSA-N 1-piperidin-1-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCCCC1 RESPXSHDJQUNTN-UHFFFAOYSA-N 0.000 claims description 2
JRXBDHSNGXRXQG-UHFFFAOYSA-N 2-(prop-2-enoylamino)butanoic acid Chemical compound CCC(C(O)=O)NC(=O)C=C JRXBDHSNGXRXQG-UHFFFAOYSA-N 0.000 claims description 2
AIHDNLMBKLUVCV-UHFFFAOYSA-N 2-(prop-2-enoylamino)hexanoic acid Chemical compound CCCCC(C(O)=O)NC(=O)C=C AIHDNLMBKLUVCV-UHFFFAOYSA-N 0.000 claims description 2
PPRBGMXQDAMDAB-UHFFFAOYSA-N 2-(prop-2-enoylamino)propanoic acid Chemical compound OC(=O)C(C)NC(=O)C=C PPRBGMXQDAMDAB-UHFFFAOYSA-N 0.000 claims description 2
SQOBXMJXKGLWNQ-UHFFFAOYSA-N 4,5-diaminopent-1-en-3-one Chemical compound NCC(N)C(=O)C=C SQOBXMJXKGLWNQ-UHFFFAOYSA-N 0.000 claims description 2
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 2
239000004395 L-leucine Substances 0.000 claims description 2
LZCXCXDOGAEFQX-UHFFFAOYSA-N N-Acryloylglycine Chemical compound OC(=O)CNC(=O)C=C LZCXCXDOGAEFQX-UHFFFAOYSA-N 0.000 claims description 2
101100074998 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) nmp-2 gene Proteins 0.000 claims description 2
239000007864 aqueous solution Substances 0.000 claims description 2
229960003136 leucine Drugs 0.000 claims description 2
229960004452 methionine Drugs 0.000 claims description 2
150000004702 methyl esters Chemical class 0.000 claims description 2
125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims 1
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 32
YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane Natural products ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 25
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
239000000243 solution Substances 0.000 description 17
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 11
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 10
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
XTUSEBKMEQERQV-UHFFFAOYSA-N propan-2-ol;hydrate Chemical compound O.CC(C)O XTUSEBKMEQERQV-UHFFFAOYSA-N 0.000 description 7
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 6
238000001914 filtration Methods 0.000 description 6
239000000203 mixture Substances 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 6
-1 Boc group Chemical group 0.000 description 5
238000004458 analytical method Methods 0.000 description 5
HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
239000002904 solvent Substances 0.000 description 4
VWWKKDNCCLAGRM-GVXVVHGQSA-N (2s)-2-[[2-[[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]propanoyl]amino]acetyl]amino]-3-methylbutanoic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O VWWKKDNCCLAGRM-GVXVVHGQSA-N 0.000 description 3
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 3
SECXISVLQFMRJM-UHFFFAOYSA-N NMP Substances CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
239000000706 filtrate Substances 0.000 description 3
108010009932 leucyl-alanyl-glycyl-valine Proteins 0.000 description 3
FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
FUKOTTQGWQVMQB-UHFFFAOYSA-N (2-bromoacetyl) 2-bromoacetate Chemical compound BrCC(=O)OC(=O)CBr FUKOTTQGWQVMQB-UHFFFAOYSA-N 0.000 description 2
ZQEBQGAAWMOMAI-ZETCQYMHSA-N (2s)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1CCC[C@H]1C(O)=O ZQEBQGAAWMOMAI-ZETCQYMHSA-N 0.000 description 2
CNBUSIJNWNXLQQ-NSHDSACASA-N (2s)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CNBUSIJNWNXLQQ-NSHDSACASA-N 0.000 description 2
NDKDFTQNXLHCGO-UHFFFAOYSA-N 2-(9h-fluoren-9-ylmethoxycarbonylamino)acetic acid Chemical compound C1=CC=C2C(COC(=O)NCC(=O)O)C3=CC=CC=C3C2=C1 NDKDFTQNXLHCGO-UHFFFAOYSA-N 0.000 description 2
RJPKQCFHEPPTGL-ZLUOBGJFSA-N Cys-Ser-Asp Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RJPKQCFHEPPTGL-ZLUOBGJFSA-N 0.000 description 2
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
IBMVEYRWAWIOTN-UHFFFAOYSA-N L-Leucyl-L-Arginyl-L-Proline Natural products CC(C)CC(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O IBMVEYRWAWIOTN-UHFFFAOYSA-N 0.000 description 2
WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 2
JKGHDYGZRDWHGA-SRVKXCTJSA-N Leu-Asn-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JKGHDYGZRDWHGA-SRVKXCTJSA-N 0.000 description 2
DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 2
108700020796 Oncogene Proteins 0.000 description 2
CGOMLCQJEMWMCE-STQMWFEESA-N Phe-Arg-Gly Chemical compound NC(N)=NCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 CGOMLCQJEMWMCE-STQMWFEESA-N 0.000 description 2
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
QKQDTEYDEIJPNK-GUBZILKMSA-N Ser-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CO QKQDTEYDEIJPNK-GUBZILKMSA-N 0.000 description 2
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
AMXMBCAXAZUCFA-RHYQMDGZSA-N Thr-Leu-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AMXMBCAXAZUCFA-RHYQMDGZSA-N 0.000 description 2
RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 2
GGXUDPQWAWRINY-XEGUGMAKSA-N Tyr-Ile-Gly Chemical compound OC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GGXUDPQWAWRINY-XEGUGMAKSA-N 0.000 description 2
JAGGEZACYAAMIL-CQDKDKBSSA-N Tyr-Lys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CC=C(C=C1)O)N JAGGEZACYAAMIL-CQDKDKBSSA-N 0.000 description 2
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical class [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 2
230000022131 cell cycle Effects 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
108010089804 glycyl-threonine Proteins 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
238000004128 high performance liquid chromatography Methods 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
239000008188 pellet Substances 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
229920005990 polystyrene resin Polymers 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 2
238000011282 treatment Methods 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
DMBKPDOAQVGTST-LBPRGKRZSA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylmethoxypropanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)COCC1=CC=CC=C1 DMBKPDOAQVGTST-LBPRGKRZSA-N 0.000 description 1
AYMLQYFMYHISQO-QMMMGPOBSA-N (2s)-3-(1h-imidazol-3-ium-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CN=CN1 AYMLQYFMYHISQO-QMMMGPOBSA-N 0.000 description 1
ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
125000003287 1H-imidazol-4-ylmethyl group Chemical group [H]N1C([H])=NC(C([H])([H])[*])=C1[H] 0.000 description 1
VRPJIFMKZZEXLR-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid Chemical compound CC(C)(C)OC(=O)NCC(O)=O VRPJIFMKZZEXLR-UHFFFAOYSA-N 0.000 description 1
TZGPACAKMCUCKX-UHFFFAOYSA-N 2-hydroxyacetamide Chemical group NC(=O)CO TZGPACAKMCUCKX-UHFFFAOYSA-N 0.000 description 1
JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
241000024188 Andala Species 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
125000000030 D-alanine group Chemical group [H]N([H])[C@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 1
GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
MDXGYYOJGPFFJL-QMMMGPOBSA-N N(alpha)-t-butoxycarbonyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)OC(C)(C)C MDXGYYOJGPFFJL-QMMMGPOBSA-N 0.000 description 1
NFVNYBJCJGKVQK-ZDUSSCGKSA-N N-[(Tert-butoxy)carbonyl]-L-tryptophan Chemical compound C1=CC=C2C(C[C@H](NC(=O)OC(C)(C)C)C(O)=O)=CNC2=C1 NFVNYBJCJGKVQK-ZDUSSCGKSA-N 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
229960003767 alanine Drugs 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
KPGVUOQMOHGHEW-LBPRGKRZSA-N boc-his(dnp)-oh Chemical compound C1=NC(C[C@H](NC(=O)OC(C)(C)C)C(O)=O)=CN1C1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O KPGVUOQMOHGHEW-LBPRGKRZSA-N 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000007822 coupling agent Substances 0.000 description 1
DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
239000012530 fluid Substances 0.000 description 1
ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical class C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 description 1
NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
125000005395 methacrylic acid group Chemical group 0.000 description 1
UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
HNKJADCVZUBCPG-UHFFFAOYSA-N thioanisole Chemical compound CSC1=CC=CC=C1 HNKJADCVZUBCPG-UHFFFAOYSA-N 0.000 description 1
ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Analytical Chemistry (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Polymerization Catalysts (AREA)

NL8902361A 1988-09-24 1989-09-21 Peptidesynthese in vaste fase. NL8902361A (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB888822502A GB8822502D0 (en)	1988-09-24	1988-09-24	New peptide synthesis method
GB8822502		1988-09-24

Publications (1)

Publication Number	Publication Date
NL8902361A true NL8902361A (nl)	1990-04-17

Family

ID=10644204

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8902361A NL8902361A (nl)	1988-09-24	1989-09-21	Peptidesynthese in vaste fase.

Country Status (30)

Country	Link
JP (1)	JPH0768265B2 (fr)
KR (1)	KR900004761A (fr)
AR (1)	AR244701A1 (fr)
AT (1)	AT400439B (fr)
AU (1)	AU622705B2 (fr)
BE (1)	BE1002237A3 (fr)
CA (1)	CA1333441C (fr)
CH (1)	CH679672A5 (fr)
DE (1)	DE3931731C2 (fr)
DK (1)	DK468589A (fr)
ES (1)	ES2018924A6 (fr)
FI (1)	FI101474B (fr)
FR (1)	FR2636951B1 (fr)
GB (2)	GB8822502D0 (fr)
GR (1)	GR1000564B (fr)
HK (1)	HK47792A (fr)
IE (1)	IE62008B1 (fr)
IT (1)	IT1231960B (fr)
LU (1)	LU87592A1 (fr)
MA (1)	MA21633A1 (fr)
MY (1)	MY106567A (fr)
NL (1)	NL8902361A (fr)
NO (1)	NO175593C (fr)
NZ (1)	NZ230712A (fr)
OA (1)	OA09243A (fr)
PT (1)	PT91784B (fr)
SE (1)	SE8903121L (fr)
SG (1)	SG40692G (fr)
TN (1)	TNSN89104A1 (fr)
ZA (1)	ZA897151B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5811241A (en) *	1995-09-13	1998-09-22	Cortech, Inc.	Method for preparing and identifying N-substitued 1,4-piperazines and N-substituted 1,4-piperazinediones
HU229701B1 (en) *	2000-12-22	2014-05-28	Ipsen Manufactoring Ireland Ltd	Process for the synthesis of a peptide having a trp residue

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3951741A (en) *	1973-07-10	1976-04-20	Peter Pfaender	Process and apparatus for the synthesis of peptides by use of n-carboxyanhydrides
US4439545A (en) *	1981-11-19	1984-03-27	Societe D "Expansion Scientifique "Expansia"	Acrylic copolymers of N-acryloylpolymethyleneimines or N-acryloyldialkylamides, N,N'-acryloyldiaminoalcanes and N-acryloylaminoacids (or esters) their preparation and use as cation exchangers

1988
- 1988-09-24 GB GB888822502A patent/GB8822502D0/en active Pending
1989
- 1989-09-18 GR GR890100587A patent/GR1000564B/el unknown
- 1989-09-19 BE BE8901003A patent/BE1002237A3/fr not_active IP Right Cessation
- 1989-09-19 ZA ZA897151A patent/ZA897151B/xx unknown
- 1989-09-20 NZ NZ230712A patent/NZ230712A/en unknown
- 1989-09-20 AT AT0219989A patent/AT400439B/de not_active IP Right Cessation
- 1989-09-20 AR AR89314966A patent/AR244701A1/es active
- 1989-09-21 ES ES8903198A patent/ES2018924A6/es not_active Expired - Lifetime
- 1989-09-21 FR FR898912394A patent/FR2636951B1/fr not_active Expired - Fee Related
- 1989-09-21 MY MYPI89001300A patent/MY106567A/en unknown
- 1989-09-21 LU LU87592A patent/LU87592A1/fr unknown
- 1989-09-21 NL NL8902361A patent/NL8902361A/nl active Search and Examination
- 1989-09-21 CH CH3435/89A patent/CH679672A5/fr not_active IP Right Cessation
- 1989-09-22 PT PT91784A patent/PT91784B/pt active IP Right Revival
- 1989-09-22 OA OA59652A patent/OA09243A/xx unknown
- 1989-09-22 MA MA21887A patent/MA21633A1/fr unknown
- 1989-09-22 AU AU41614/89A patent/AU622705B2/en not_active Ceased
- 1989-09-22 IT IT8921804A patent/IT1231960B/it active
- 1989-09-22 JP JP1245374A patent/JPH0768265B2/ja not_active Expired - Lifetime
- 1989-09-22 FI FI894489A patent/FI101474B/fi not_active IP Right Cessation
- 1989-09-22 TN TNTNSN89104A patent/TNSN89104A1/fr unknown
- 1989-09-22 SE SE8903121A patent/SE8903121L/ not_active Application Discontinuation
- 1989-09-22 DE DE3931731A patent/DE3931731C2/de not_active Expired - Fee Related
- 1989-09-22 NO NO893773A patent/NO175593C/no not_active IP Right Cessation
- 1989-09-22 IE IE303789A patent/IE62008B1/en not_active IP Right Cessation
- 1989-09-22 DK DK468589A patent/DK468589A/da not_active Application Discontinuation
- 1989-09-22 CA CA000612438A patent/CA1333441C/fr not_active Expired - Fee Related
- 1989-09-23 KR KR1019890013716A patent/KR900004761A/ko not_active Ceased
- 1989-09-25 GB GB8921637A patent/GB2223227B/en not_active Expired - Fee Related
1992
- 1992-04-14 SG SG406/92A patent/SG40692G/en unknown
- 1992-07-02 HK HK477/92A patent/HK47792A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
ZA897151B (en)	1990-06-27
GB8921637D0 (en)	1989-11-08
IE62008B1 (en)	1994-12-14
NO893773D0 (no)	1989-09-22
MA21633A1 (fr)	1990-04-01
JPH0768265B2 (ja)	1995-07-26
NZ230712A (en)	1991-07-26
DE3931731C2 (de)	1996-06-13
IT8921804A0 (it)	1989-09-22
CA1333441C (fr)	1994-12-06
FI894489L (fi)	1990-03-25
DE3931731A1 (de)	1990-03-29
GR1000564B (el)	1992-08-26
AR244701A1 (es)	1993-11-30
BE1002237A3 (fr)	1990-10-30
IE893037L (en)	1990-03-24
SE8903121D0 (sv)	1989-09-22
ES2018924A6 (es)	1991-05-16
SG40692G (en)	1992-06-12
NO893773L (no)	1990-03-26
TNSN89104A1 (fr)	1991-02-04
PT91784A (pt)	1990-03-30
HK47792A (en)	1992-07-10
AT400439B (de)	1995-12-27
FR2636951A1 (fr)	1990-03-30
OA09243A (en)	1992-06-30
ATA219989A (de)	1995-05-15
GB8822502D0 (en)	1988-10-26
JPH02129200A (ja)	1990-05-17
FI101474B1 (fi)	1998-06-30
CH679672A5 (fr)	1992-03-31
DK468589D0 (da)	1989-09-22
GB2223227A (en)	1990-04-04
FR2636951B1 (fr)	1991-03-08
FI894489A0 (fi)	1989-09-22
NO175593C (no)	1994-11-02
FI101474B (fi)	1998-06-30
AU622705B2 (en)	1992-04-16
DK468589A (da)	1990-03-25
LU87592A1 (fr)	1990-01-08
NO175593B (no)	1994-07-25
KR900004761A (ko)	1990-04-13
GB2223227B (en)	1992-01-15
AU4161489A (en)	1990-03-29
SE8903121L (sv)	1990-03-25
IT1231960B (it)	1992-01-16
PT91784B (pt)	1996-01-31
GR890100587A (en)	1990-10-31
MY106567A (en)	1995-06-30

Legal Events

Date	Code	Title
1991-10-01	BA	A request for search or an international-type search has been filed
1991-10-01	BB	A search report has been drawn up
1992-02-03	BC	A request for examination has been filed
2001-05-01	BN	A decision not to publish the application has become irrevocable

Publication	Publication Date	Title
CA1318462C (fr)	1993-05-25	Resine synthetique
US3929758A (en)	1975-12-30	Cyclization of cysteine-containing peptides
US4033940A (en)	1977-07-05	Cyclization of peptides
GB1570375A (en)	1980-07-02	Synthetic antigenically active polypeptide and a process for its preparation
US20130172529A1 (en)	2013-07-04	Method for synthesizing thymosins
EP0619118A1 (fr)	1994-10-12	Utilisation de dérivés peptidiques
US6897289B1 (en)	2005-05-24	Peptide synthesis procedure in solid phase
JP2925523B2 (ja)	1999-07-28	固相ペプチド合成法
BG60621B1 (bg)	1995-10-31	Нов полипептид и анти-hiv лекарство, получено от него
US5128447A (en)	1992-07-07	Synthetic peptide antagonists of neurokinin a, salts thereof and respective preparation processes
US5175254A (en)	1992-12-29	Solid phase peptide synthesis using a polyacrylic support in aqueous solution
RU2249599C2 (ru)	2005-04-10	Циклопептиды, способ их получения и применение в качестве ингибиторов или активаторов антиогенеза
AU2002316989B2 (en)	2006-10-26	Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
CA1157466A (fr)	1983-11-22	Peptides ayant des proprietes ressemblant a celles de la thymopoietine
NL8902361A (nl)	1990-04-17	Peptidesynthese in vaste fase.
JPS61246199A (ja)	1986-11-01	免疫原性ｈａｖペプチド
US4327075A (en)	1982-04-27	Synthetic antigenically-active polypeptide and a process for its preparation
CN103833831A (zh)	2014-06-04	一种卡贝缩宫素的制备方法
US4389342A (en)	1983-06-21	Synthetic hormone-like peptides and method for their synthesis
US4242238A (en)	1980-12-30	Synthesis of peptides
JP2777193B2 (ja)	1998-07-16	ペプチドの製造方法
JPH0338599A (ja)	1991-02-19	抗ｈｉｖペプチド及び抗ｈｉｖ修飾ペプチド
Roy et al.	1975	OXYTOCIN ANALOGS WITH SUBSTITUTIONS IN POSITIONS 3 AND 4. Synthesis and some pharmacological properties
Chang et al.	1979	Synthesis of [Gln4]-neurotensin using a new solid support, the 4-(hydroxymethyl) phenylacetamidomethyl-resin
GB1586974A (en)	1981-03-25	Synthesis of peptide amides